Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nouryon (formerly AkzoNobel Specialty Chemicals) is a global leader in specialty chemicals and a key supplier to the pharmaceutical and healthcare industries. The company's Polymer Chemistry business, previously known as AkzoNobel Polymer Chemicals, provides essential ingredients such as organic peroxides, metal alkyls, and chromatography media (Kromasil) used in the synthesis and purification of active pharmaceutical ingredients (APIs). Nouryon's products are vital for the production of various medications, including acne treatments (benzoyl peroxide), cardiovascular drugs (statins), and antibiotics. In addition to its product portfolio, Nouryon offers custom synthesis and CDMO services to support pharmaceutical development and manufacturing. Headquartered in Amsterdam, the company operates a global network of manufacturing and R&D facilities and has been an independent entity owned by The Carlyle Group and GIC since 2018.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Akzo Nobel Polymer Chem.